Instituto Rosenbusch S.A. (BCBA:ROSE)

Market Cap	6.84B +52.9%
Revenue (ttm)	6.40B -41.2%
Net Income	-4.60B
EPS	-107.95
Shares Out	42.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,200
Open	163.00
Previous Close	161.50
Day's Range	160.50 - 163.00
52-Week Range	116.00 - 415.00
Beta	0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 24, 2026

About Instituto Rosenbusch

Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1917
• Country: Argentina
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: ROSE

Financial Performance

In 2025, Instituto Rosenbusch's revenue was 6.40 billion, a decrease of -41.17% compared to the previous year's 10.89 billion. Losses were -4.60 billion, 146.6% more than in 2024.